{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:38:46Z","timestamp":1720723126426},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Intratumoral heterogeneity has been shown to play an important role in diagnostic accuracy, development of treatment resistance, and prognosis of cancer patients. Recent studies have proposed quantitative measurement of phenotypic intratumoral heterogeneity, but no study is yet available in endometrial carcinomas. In our study we evaluated the phenotypic intratumoral heterogeneity of a consecutive series of 10 endometrial carcinomas using measures of dispersion and diversity. Morphometric architectural (%tumor cells, %solid tumor, %differentiated tumor, and %lumens) and nuclear [volume-weighted mean nuclear volume (\n                              \n                                 \n                                    \n                                       JOURNAL\/ijgyp\/04.03\/00004347-201803000-00009\/inline-formula1\/v\/2023-08-24T000032Z\/r\/image-tiff\n                                    \n                                 \n                              \n                           )] parameters, as well as estrogen receptor, progesterone receptor, p53, vimentin, and beta-catenin immunoexpression (H-score) were digitally analyzed in 20 microscopic fields per carcinoma. Quantitative measures of intratumoral heterogeneity included coefficient of variation (CV) and relative quadratic entropy (rQE). In each endometrial carcinoma there was slight variation of architecture from field to field, resulting in globally low levels of heterogeneity measures (mean CV %tumor cells: 0.10, %solid tumor: 0.73, %differentiated tumor: 0.19, %lumens: 0.61 and mean rQE %tumor cells: 18.5, %solid tumor: 20.3, %differentiated tumor: 25.6, %lumens: 21.8). Nuclear intratumoral heterogeneity was also globally low (mean \n                              \n                                 \n                                    \n                                       JOURNAL\/ijgyp\/04.03\/00004347-201803000-00009\/inline-formula2\/v\/2023-08-24T000032Z\/r\/image-tiff\n                                    \n                                 \n                              \n                            CV: 0.23 and rQE: 27.3), but significantly higher than the heterogeneity of architectural parameters within most carcinomas. In general, there was low to moderate variability of immunoexpression markers within each carcinoma, but estrogen receptor (mean CV: 0.56 and rQE: 46.2) and progesterone receptor (mean CV: 0.60 and rQE: 39.3) displayed the highest values of heterogeneity measures. Intratumoral heterogeneity of immunoexpression was significantly higher than that observed for morphometric parameters. In conclusion, our study indicates that endometrial carcinomas present a variable but predominantly low degree of phenotypic intratumoral heterogeneity.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000400","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T18:24:23Z","timestamp":1496427863000},"page":"154-166","source":"Crossref","is-referenced-by-count":3,"title":["Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas"],"prefix":"10.1097","volume":"37","author":[{"given":"C\u00e1tia","family":"Silva","sequence":"first","affiliation":[]},{"given":"Ana S.","family":"Pires-Lu\u00eds","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Bartosch","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/febs.13705","article-title":"Intra-tumour heterogeneity - going beyond genetics","volume":"283","author":"Caiado","year":"2016","journal-title":"FEBS J"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","article-title":"Intratumor heterogeneity: evolution through space and time","volume":"72","author":"Swanton","year":"2012","journal-title":"Cancer Res"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: a looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00004347-198703000-00002","article-title":"Morphometric analysis of endometnal adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma?","volume":"6","author":"Zaino","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20230824","first-page":"1889","article-title":"Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma","volume":"48","author":"Zaino","year":"1988","journal-title":"Cancer Res"},{"key":"R7-20230824","first-page":"95","article-title":"Immunohistochemical study of HER-2\/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium","volume":"79","author":"Bigsby","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/02841869709100726","article-title":"Flow cytometric DNA-heterogeneity in paraffin-embedded endometrial cancer","volume":"36","author":"Rosenberg","year":"1997","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/gyno.2000.5858","article-title":"Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas","volume":"78","author":"Faquin","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R10-20230824","first-page":"115","article-title":"Apoptosis, proliferation, and hormone receptors in endometrial carcinoma: results depending on methods of analysis","volume":"22","author":"Dahmoun","year":"2003","journal-title":"Int J Oncol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00428-005-0029-9","article-title":"Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas","volume":"447","author":"Feng","year":"2005","journal-title":"Virchows Arch"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/PGP.0b013e3181e2e8ee","article-title":"DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens","volume":"29","author":"Pradhan","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/gcc.22113","article-title":"Marked heterogeneity of HER2\/NEU gene amplification in endometrial serous carcinoma","volume":"52","author":"Buza","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tranon.2014.06.001","article-title":"Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer","volume":"7","author":"Supernat","year":"2014","journal-title":"Transl Oncol"},{"key":"R15-20230824","first-page":"134","article-title":"Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mod Pathol","volume":"30","author":"Mota","year":"2017"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0142(19840101)53:1<113::AID-CNCR2820530120>3.0.CO;2-F","article-title":"Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma","volume":"53","author":"Mortel","year":"1984","journal-title":"Cancer"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1525-1438.1995.05020087.x","article-title":"Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study","volume":"5","author":"Alm","year":"1995","journal-title":"Int J Gynecol Cancer"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2559.2003.01603.x","article-title":"Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens","volume":"42","author":"Mitchard","year":"2003","journal-title":"Histopathology"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2008.12.017","article-title":"Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma","volume":"113","author":"Leitao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"e0134969","DOI":"10.1371\/journal.pone.0134969","article-title":"Endometrial endometrioid carcinoma metastases show decreased ER-Alpha and PR-A expression compared to matched primary tumors","volume":"10","author":"Bartosch","year":"2015","journal-title":"PLoS One"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/PAS.0b013e318273591a","article-title":"Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma","volume":"36","author":"Soslow","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajpath.2013.07.015","article-title":"Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients","volume":"183","author":"Onsum","year":"2013","journal-title":"Am J Pathol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00428-015-1865-x","article-title":"A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data","volume":"467","author":"Plancoulaine","year":"2015","journal-title":"Virchows Arch"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/labinvest.2012.91","article-title":"Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue","volume":"92","author":"Potts","year":"2012","journal-title":"Lab Invest"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00004347-198703000-00003","article-title":"Morphometric analysis of endometrial adenocarcinoma: 2. A comparison of architectural differentiation determined morphometrically with subjective grading","volume":"6","author":"Zaino","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1985.tb02607.x","article-title":"Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections","volume":"138","author":"Gundersen","year":"1985","journal-title":"J Microsc"},{"key":"R28-20230824","first-page":"1","article-title":"Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors","volume":"79","author":"Ladekarl","year":"1998","journal-title":"APMIS Suppl"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2559.1993.tb00063.x","article-title":"Stereological estimate of nuclear volume in endometrial adenocarcinoma of endometrioid type: reproducibility and intra-tumour variation","volume":"22","author":"Nielsen","year":"1993","journal-title":"Histopathology"},{"key":"R30-20230824","first-page":"443","article-title":"Evaluation of volume-weighted mean nuclear volume in endometrial lesions","volume":"8","author":"Artacho-Perula","year":"1993","journal-title":"Histol Histopathol"},{"key":"R31-20230824","first-page":"4","article-title":"Quantitative analysis of nuclear size for objective malignancy grading: a review with emphasis on new, unbiased stereologic methods","volume":"66","author":"Sorensen","year":"1992","journal-title":"Lab Invest"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<956::AID-CNCR22>3.0.CO;2-T","article-title":"Prognostic impact of morphometric nuclear grade of endometrial carcinoma","volume":"83","author":"Salvesen","year":"1998","journal-title":"Cancer"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/109442810033005","article-title":"On the use of the coefficient of variation as a measure of diversity","volume":"3","author":"Bedeian","year":"2000","journal-title":"Organ Res Method"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tpb.2005.01.004","article-title":"Measuring diversity from dissimilarities with Rao\u2019s quadratic entropy: are any dissimilarities suitable?","volume":"67","author":"Pavoine","year":"2005","journal-title":"Theor Popul Biol"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000010159","article-title":"Gene expression in primary, metastatic and recurrent lesions of endometrial cancer","volume":"48","author":"Sakamoto","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nat Genet"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1111\/j.1742-4658.2012.08810.x","article-title":"Beyond genotype to phenotype: why the phenotype of an individual cannot always be predicted from their genome sequence and the environment that they experience","volume":"279","author":"Burga","year":"2012","journal-title":"FEBS J"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2559.1981.tb01835.x","article-title":"Quantitative, microscopical, computer-aided diagnosis of endometrial hyperplasia or carcinoma in individual patients","volume":"5","author":"Baak","year":"1981","journal-title":"Histopathology"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1711540409","article-title":"Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone","volume":"154","author":"Baak","year":"1988","journal-title":"J Pathol"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<462::AID-PATH590>3.0.CO;2-D","article-title":"Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry","volume":"190","author":"Mutter","year":"2000","journal-title":"J Pathol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.humpath.2007.09.023","article-title":"Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study","volume":"39","author":"Mutter","year":"2008","journal-title":"Human Pathol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-9-77","article-title":"Distribution of estrogen and progesterone receptors isoforms in endometrial cancer","volume":"9","author":"Kreizman-Shefer","year":"2014","journal-title":"Diagn Pathol"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IGC.0b013e31820575f5","article-title":"Evolution in endometrial cancer: evidence from an immunohistochemical study","volume":"21","author":"Vandenput","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.ejca.2014.09.003","article-title":"Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions","volume":"50","author":"Tangen","year":"2014","journal-title":"Eur J Cancer"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-200201000-00003","article-title":"A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas","volume":"21","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis","volume":"19","author":"Reid-Nicholson","year":"2006","journal-title":"Mod Pathol"},{"key":"R48-20230824","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.0.CO;2-4","article-title":"Nuclear localization of beta-catenin in normal and carcinogenic endometrium","volume":"25","author":"Nei","year":"1999","journal-title":"Mol Carcinog"},{"key":"R49-20230824","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004280000371","article-title":"Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability","volume":"438","author":"Palacios","year":"2001","journal-title":"Virchows Archiv"},{"key":"R50-20230824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1581","article-title":"beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis","volume":"84","author":"Saegusa","year":"2001","journal-title":"Br J Cancer"},{"key":"R51-20230824","doi-asserted-by":"crossref","first-page":"e102678","DOI":"10.1371\/journal.pone.0102678","article-title":"Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery","volume":"9","author":"Gough","year":"2014","journal-title":"PLoS One"},{"key":"R52-20230824","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3800(00)00203-9","article-title":"A link between ecological diversity indices and measures of biodiversity","volume":"130","author":"Izs\u00e1k","year":"2000","journal-title":"Ecol Modell"},{"key":"R53-20230824","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1200\/JCO.2012.43.1890","article-title":"Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma","volume":"30","author":"Yoon","year":"2012","journal-title":"J Clin Oncol"},{"key":"R54-20230824","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/gim.2016.81","article-title":"Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia","volume":"19","author":"Yi","year":"2017","journal-title":"Genet Med"},{"key":"R55-20230824","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","article-title":"Genetic clonal diversity predicts progression to esophageal adenocarcinoma","volume":"38","author":"Maley","year":"2006","journal-title":"Nat Genet"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201803000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:33:11Z","timestamp":1692840791000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201803000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000400","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}